SlideShare uma empresa Scribd logo
1 de 3
Find Industry reports, Company profiles
ReportLinker                                                                      and Market Statistics



                                               >> Get this Report Now by email!

Intas Biopharmaceuticals Ltd.-Company Report
Published on April 2010

                                                                                                            Report Summary

Intas Biopharmaceuticals Ltd.-Company Report provides up to date insight into the structure and operations of privately-held
pharmaceutical, biotechnology and biomedical companies.


Scope of the reports


Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has
created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and
business description along with detail on the company's management team and its products. .


Key benefits


   * Private Company Reports deliver independent insight into a company's operations and products - vital intelligence for investors,
competitors and partners.
   * Save both time and money by instantly accessing private company data that can be difficult to source independently.




                                                                                                             Table of Content

Business Summary
Product Glance
--Products by Phase of Development
--Products by Disease Hub Classification
--Products by Indication
Product Summary
Product Details
Recent Updates




Intas Biopharmaceuticals Ltd.-Company Report                                                                                    Page 1/3
Find Industry reports, Company profiles
ReportLinker                                                                             and Market Statistics


             Fax Order Form
             To place an order via fax simply print this form, fill in the information below and fax the completed form to:
                          Europe, Middle East and Africa : + 33 4 37 37 15 56
                          Asia, Oceania and America : + 1 (805) 617 17 93
             If you have any questions please visit http://www.reportlinker.com/notify/contact


             Order Information
             Please verify that the product information is correct and select the format(s) you require.

                   Intas Biopharmaceuticals Ltd.-Company Report




             Product Formats
             Please select the product formats and the quantity you require.

                                    1 User License--USD 750.00                  Quantity: _____



                                    Corporate License--USD 1 875.00             Quantity: _____




             Contact Information
             Please enter all the information below in BLOCK CAPITALS


             Title:                   Mr               Mrs            Dr                  Miss             Ms                 Prof

             First Name:                   _____________________________ Last Name: __________________________________

             Email Address:              __________________________________________________________________________

             Job Title:                   __________________________________________________________________________

             Organization:                __________________________________________________________________________

             Address:                     __________________________________________________________________________

             City:                        __________________________________________________________________________

             Postal / Zip Code:            __________________________________________________________________________

             Country:                     __________________________________________________________________________

             Phone Number:                __________________________________________________________________________

             Fax Number:                 __________________________________________________________________________




Intas Biopharmaceuticals Ltd.-Company Report                                                                                         Page 2/3
Find Industry reports, Company profiles
ReportLinker                                                                            and Market Statistics


             Payment Information
             Please indicate the payment method, you would like to use by selecting the appropriate box.




                    Payment by credit card             Card Number: ______________________________________________


                                                       Expiry Date     __________ / _________


                                                       CVV Number _____________________


                                                       Card Type (ex: Visa, Amex…) _________________________________




                    Payment by wire transfer           Crédit Mutuel
                                                       RIB : 10278 07314 00020257701 89
                                                       BIC : CMCIFR2A
                                                       IBAN : FR76 1027 8073 1400 0202 5770 189




                     Payment by check                  UBIQUICK SAS
                                                       16 rue Grenette – 69002 LYON, FRANCE




                                 Customer signature:

                                  




             Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
             http://www.reportlinker.com/index/terms




                                                        Please fax this form to:

                                               Europe, Middle East and Africa : + 33 4 37 37 15 56

                                                Asia, Oceania and America : + 1 (805) 617 17 93




Intas Biopharmaceuticals Ltd.-Company Report                                                                           Page 3/3

Mais conteúdo relacionado

Mais de ReportLinker.com

Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?ReportLinker.com
 
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoInterview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
 
Tutorial for the ReportLinker App
Tutorial for the ReportLinker AppTutorial for the ReportLinker App
Tutorial for the ReportLinker AppReportLinker.com
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryReportLinker.com
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming IndustryReportLinker.com
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013ReportLinker.com
 

Mais de ReportLinker.com (20)

Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?
 
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoInterview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
 
Tutorial for the ReportLinker App
Tutorial for the ReportLinker AppTutorial for the ReportLinker App
Tutorial for the ReportLinker App
 
Samsung customer loyalty
Samsung customer loyaltySamsung customer loyalty
Samsung customer loyalty
 
Project Caf
Project CafProject Caf
Project Caf
 
Project Caf
Project CafProject Caf
Project Caf
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
 
 
 
Thisisatest
ThisisatestThisisatest
Thisisatest
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes Industry
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming Industry
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013
 

Último

Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncrdollysharma2066
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Pereraictsugar
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyotictsugar
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportMintel Group
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCRashishs7044
 
8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCRashishs7044
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?Olivia Kresic
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Anamaria Contreras
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607dollysharma2066
 
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxMarkAnthonyAurellano
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckHajeJanKamps
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 

Último (20)

Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Perera
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyot
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample Report
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR
 
8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?
 
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
 
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 

Intas Biopharmaceuticals Ltd.-Company Report

  • 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Intas Biopharmaceuticals Ltd.-Company Report Published on April 2010 Report Summary Intas Biopharmaceuticals Ltd.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company's management team and its products. . Key benefits * Private Company Reports deliver independent insight into a company's operations and products - vital intelligence for investors, competitors and partners. * Save both time and money by instantly accessing private company data that can be difficult to source independently. Table of Content Business Summary Product Glance --Products by Phase of Development --Products by Disease Hub Classification --Products by Indication Product Summary Product Details Recent Updates Intas Biopharmaceuticals Ltd.-Company Report Page 1/3
  • 2. Find Industry reports, Company profiles ReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Intas Biopharmaceuticals Ltd.-Company Report Product Formats Please select the product formats and the quantity you require. 1 User License--USD 750.00 Quantity: _____ Corporate License--USD 1 875.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Intas Biopharmaceuticals Ltd.-Company Report Page 2/3
  • 3. Find Industry reports, Company profiles ReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Intas Biopharmaceuticals Ltd.-Company Report Page 3/3